## Gene Summary
GSTP1, or Glutathione S-transferase Pi 1, is a member of the glutathione S-transferase family, which plays critical roles in the detoxification of electrophilic compounds by conjugation with glutathione. GSTP1 is involved in the metabolism of xenobiotics (chemical substances foreign to the biological system) and has a significant role in the detoxification pathway. This gene is known for its expression primarily in the liver but can also be found in many other tissues, including lung and kidney. It functions as a homodimer and is involved in the protection against oxidative stress and the metabolic processing of various toxins, carcinogens, and therapeutic drugs.

## Gene Drugs, Diseases, Phenotypes, and Pathways
GSTP1 is implicated in the metabolism of a broad range of therapeutic drugs and environmental toxins. It is notably associated with various phenotypes, particularly those influencing the bodyâ€™s response to oxidative stress and susceptibility to toxic insults. The gene is involved in broad pathways, including those linked to the metabolism of carcinogens, drugs, and products of oxidative stress. GSTP1 dysfunction or polymorphisms are studied in various diseases, notably in cancers such as breast cancer and prostate cancer, where its suppression or modification is often observed. It also plays a role in resistance to chemotherapy in cancer treatment.

## Pharmacogenetics
GSTP1 is significant in pharmacogenetics primarily due to its role in drug metabolism and its influence on the efficacy and toxicity of drugs. Variants of GSTP1 can alter enzyme activity and, thus, individual responses to drugs and susceptibility to adverse effects. For instance, certain polymorphisms in GSTP1 are known to impact the metabolism of chemotherapeutic agents like cisplatin and carboplatin, used in the treatment of various cancers. The Ile105Val polymorphism, in particular, has been associated with different outcomes in cancer therapy, influencing both toxicity and therapeutic effectiveness. This variant can modify the detoxification potential of GSTP1, thereby affecting drug effectiveness and patient's response to treatment. The understanding of these pharmacogenetic associations is crucial for tailoring personalized therapeutic strategies and minimizing drug-related toxicities.